1q21 is frequently involved in dierent types of translocation in many types of cancers. Jumping translocation (JT) is an unbalanced translocation that comprises ampli®ed chromosomal segments jumping to various telomeres. In this study, we identi®ed a novel gene human JTB (Jumping Translocation Breakpoint) at 1q21, which fused with the telomeric repeats of acceptor telomeres in a case of JT. hJTB (human JTB) encodes a trans-membrane protein that is highly conserved among divergent eukaryotic species. JT results in a hJTB truncation, which potentially produces an hJTB product devoid of the trans-membrane domain. hJTB is located in a gene-rich region at 1q21, called EDC (Epidermal Dierentiation Complex). This is the ®rst report identifying the gene involved in unbalanced translocations at 1q21.
Introduction
Many types of chromosomal aberrations have been reported as being associated with diverse sets of cancers (Solomon et al., 1991) . Among them, chromosome translocations involving the long arm of chromosome 1 (1q) are one of the most frequently observed anomalies (Ot et al., 1991; Bernheim and Berger, 1988) . Speci®cally, partial duplications of 1q, involving variable segments but always including 1q21-23, are the most often reported (for example, 5/20 of the Ewing family of tumors (Armengol et al., 1997) , 16/25 of renal clear cell carcinoma (Gronwald et al., 1997) , 29 ± 50% of liposarcoma (Szymanska et al., 1996 (Szymanska et al., , 1997 ). However, there has been no report indicating which speci®c genes are involved in these partial duplications at 1q21.
Jumping translocation (JT) is an unusual form of partial chromosomal duplication in which ampli®ed speci®c chromosomal segments are translocated onto the ends of various chromosomes (jumps). About 20 cases of JT have been reported in leukemia patients (Shippey et al., 1990) . In most cases, the regions distal to 1q11 or 1q21 had jumped onto various chromosomal tips. We previously reported a molecular study of one AMMoL patient with JTs in which a region distal to 1q21 fused with many telomeres (Hatakeyama et al., 1998) . We demonstrated for the ®rst time that JTs comprise fusions between donor breakpoints (1q21 in this case) and the telomeric repeats of acceptor chromosomes. Signi®cantly, it was found that variant telomeric repeats, such at TTGGGG, which have onebase substitutions in the canonical telomeric repeat TTAGGG, were dominant at the fusion points. These variant telomeric repeats are known to be present at the most centromeric (proximal) regions of the telomeres (Flint et al., 1997) . Furthermore, it has been reported that telomeric repeats consisting solely of variant repeats might not perform some telomere functions in vivo (Hanish et al., 1994) . The patient had suered from MDS (myelodysplastic syndrome), a preleukemic state, for 10 years before the onset of AMMoL. MDS is characterized by extensive proliferation and inecient dierentiation of the hematopoietic cells. We therefore suggested that after extensive proliferation during MDS, telomeric repeats had been reduced to a level that exposed the proximal telomeric regions, leading to the loss of telomeric functions (LTF) in the hematopoietic cells in this patient (Ishikawa, 1997; Hatakeyama et al., 1998) . Simple chromosomal ends lacking telomeres are known to easily undergo end-to-end fusions (Saltman et al., 1993) . The chromosomal ends with LTF then might have fused with 1q21 to produce JT.
However, in our previous study, we did not have any indication as to why 1q21 is frequently involved in JT cases. Two possibilities, which are not mutually exclusive, can be proposed. One possibility is that some speci®c genes located at 1q21 may be activated by JT to give a growth advantage to cancer cells. In this case, JT contributes to cancer progression. The other possibility is that 1q21 may have some intrinsic DNA properties or chromosomal structures that are vulnerable to the attack of chromosomal ends lacking telomeres. In this case, JT is a simple re¯ection of the general chromosomal instability of cancer cells, that is LTF. Structural analyses of the genomic region at the 1q21 fusion point might help us to dierentiate between these two possibilities. We therefore conducted this study in which the genomic DNA around the JT fusion point was cloned and examined in detail.
Results

Identi®cation of JTB, a novel gene at the JT fusion points
In our previous study, we reported that the chromosomal segment distal to 1q21 (donor segment) had jumped to a number of dierent chromosome telomeres (acceptor telomeres) in one AMMoL patient with JT. A l phage clone containing the fused 1q21 DNA was cloned, and nucleotide sequencing of the fusion point revealed that the telomeric repeats of the acceptor chromosomes are fused with an Alu element derived from 1q21 ( Figure 1) . We then cloned a unique sequence at 1q21 that is located about 2.1 kb from the fusion point. The nucleotide sequence of this clone was obtained and used for a GenBank database search by the BLAST program. Unexpectedly, several entries having sequences identical to this clone were found in the GenBank human expression sequence tag database (dbEST), suggesting that this clone represents a gene. Northern hybridization analyses with various human cell lines and normal tissues were performed using the clone as a probe. A single band representing 1 kb of mRNA was expressed ubiquitously in almost all tissues and cell lines (Figure 2a ). The expression level was relatively high in thyroid and skeletal muscle. Kidney and spinal cord expressed an additional transcript of approximately 1.4 kb. These results con®rmed that the genomic clone we isolated from the neighbor of the JT fusion point is part of an actual gene.
Using the genomic clone, a cDNA library made from the human ovarian teratocarcinoma cell line PA-1 was screened for cDNA clones representing the transcript. Two independent clones were isolated, sequenced and found to contain a single open reading frame (ORF) potentially encoding a 146 amino acid sequence ( Figure 2b ). There is an in-frame upstream stop codon (nucleotide 223) for the ®rst ATG codon in this ORF (nucleotide 433), making it likely that this codon is used as the translation initiation codon, as shown in Figure 2b . The calculated molecular mass of the predicted amino acid sequence is 16.4 kDa. A database search of GenBank informed us that this cDNA does not show any signi®cant homology with any known gene. We therefore designated this novel human gene as human JTB (Jumping Translocation Breakpoint). Detailed analyses of the human JTB cDNA sequence revealed two potentially important features. Following the tentative initiation codon, a 30-amino acid stretch mainly composed of hydrophobic and basic amino acid residues was identi®ed, suggesting that this region corresponds to a signal sequence, a hallmark found at the N-termini of most secreted or membranous proteins. If this tentative signal sequence is processed and removed, the predicted sequence then contains 116 amino acids with a calculated molecular mass of 13.2 kDa. Another highly hydrophobic stretch of 21 amino acids was found relatively close to the Cterminal region (amino acid 106 ± 126 in Figure 2b ). This region most likely represents a trans-membrane domain. Thus, JTB may code for a novel transmembrane protein, having a 75-amino acid extracellular domain (after removal of the signal sequence), a 21-amino acid trans-membrane domain and a 20-amino acid intra-cellular domain.
To con®rm that JTB actually encoded a protein, an expression vector producing a recombinant JTB protein with a FLAG-tag sequence at the C-terminus was constructed and transfected to 293T cells. The transiently expressed protein was labeled with 35 Smethionine and 35 S-cysteine, and analysed by immunoprecipitation using the anti-FLAG antibody. As expected, a recombinant JTB protein was identi®ed in the total cell extract (Figure 2c , left). This product was Figure 1 Structure of the JT fusion point. JT is an unbalanced translocation in which the extra-copy chromosomal segment distal to 1q21 has fused with acceptor telomeres. The structures of the acceptor telomeres (upper panel), the normal 1q21 allele (lower panel) and the JT fusion point (middle panel) are schematically shown. On the acceptor telomeres, the fusion point is within the proximal region of the telomeric repeats, where variant telomeric repeats frequently exist. The fusion point on 1q21 is within an Alu element. A unique genomic sequence at 1q21 was found about 2.1 kb telomeric from the fusion point, and was used as a fusion point-speci®c probe in this study not found in the culture medium, indicating that the JTB protein is not secreted. The estimated molecular mass of the protein (16.6 kDa) was greater than expected (13.2 kDa +1.1 kDa of FLAG epitope). Since the JTB band obtained by SDS ± PAGE was somewhat diuse, it is possible that the JTB protein underwent some modi®cation. No consensus sequence for glycosylation was found.
JTB is highly conserved in diverse eukaryotic species
The human JTB cDNA sequence was used for the BLAST search to identify related sequences in the dbEST of other species. cDNA sequences potentially encoding proteins highly homologous to human JTB were identi®ed in Mus musculus and Brugia malayi (micro®laria). We also cloned and sequenced the rat JTB cDNA from a rat cDNA library constructed from the cell line SV-3Y1-C66. Therefore, JTB genes were identi®ed in human, rat, mouse and micro®laria, either by molecular cloning or database searches. Hereafter, these genes will be referred to as hJTB (human), rJTB (rat), mJTB (mouse) and BrJTB (Brugia). The predicted amino acid sequences are shown in Figure  3 ). All these JTB proteins contain 146 amino acids. Amino acid homology between hJTB, rJTB, mJTB and BrJTB were very high throughout the entire sequences. The extra-cellular domains of JTBs were characterized by the presence of regularly spaced cysteine residues: Nine cysteines with conserved numbers of intervening amino acids are present in all JTBs. Some of these cysteine residues are thought to be engaged in disul®de bond formations in the extra-cellular domain. This conserved pattern of regularly spaced cysteines is distinct from those found in the TNF receptor family, the EGF receptor family or the complement family. Therefore, JTB belongs to another group of transmembrane proteins highly conserved among diverse eukaryotes.
Genomic organization of hJTB
To analyse the structural changes of hJTB caused by JT, we have isolated seven l phage clones containing wild type hJTB genomic sequences from a normal human genomic library (Figure 4) . The point of fusion between 1q21 and the JT-acceptor telomeres was determined by comparing the genomic sequences of the wild type and fused hJTB alleles. The wild type hJTB has ®ve exons and four introns over a length of 3 kb in the orientation of telomere to centromere. The JT fusion point was localized within an Alu element present in intron 4. Therefore, it was possible that the fused hJTB allele in the patient produced an aberrant transcript devoid of exon 5. The transcript may have been either terminated by cryptic downstream poly(A)-addition signals, or spliced to unrelated exons present in the subtelomeric regions of the JT-acceptor telomeres. It is interesting that the boundary between exons 4 and 5 is precisely located on the cDNA at a position corresponding to the N-terminus of the hJTB trans-membrane domain (Figure 2b ). Thus, hJTB transcripts devoid of exon 5 are expected to produce a truncated product that lacks the trans-membrane and intra-cellular domains. This aberrant product is most likely secreted from cells. To test this possibility, we expressed an extracellular JTB recombinant protein (amino acids 1 ± 104) having an HA-tag at its Cterminus in CHO cells. In contrast to the case of the full length recombinant protein (Figure 2c, left) , signi®cant amount of the protein was found to be secreted into the culture medium (Figure 2c, right) . This result supported the hypothesis that the truncated JTB protein, presumably produced in the JT cells, might have been secreted. Due to an insucient quantity of the samples, however, it was not possible to examine whether the mutant hJTB allele was actually transcribed or not in the JT cells.
We analysed the gene dosages of this genomic region by Southern hybridization. When the breakpoint-proximal (centromeric) probe was used, the DNA derived from the patient's leukemic cells and those from two healthy donors' blood cells showed similar levels of signals, indicating that the proximal region is represented as diploid in JT cells (data not shown). In contrast, when the breakpoint-distal (telomeric) probe was used, the JT cells showed signals almost twice as high as those of the normal cells (data not shown). The degree of ampli®cation of the breakpoint-distal region in the JT cells was estimated using the proximal region as an internal control. JT cells had about 2.18-fold ampli®cation of the distal region compared to the normal cells. This estimated value is compatible with the previous observation that the patient cells consisted almost exclusively of leukemic cells having two JTs, leading to tetraploidity of the region distal to 1q21.
hJTB is localized in EDC
We extended the nucleotide sequencing of the l genomic clones, and found that two reported STSs, D1S3384 (40S ribosomal protein S27) and D1S2463, are located in the hJTB region ( Figure 5 ). These STS markers were derived from the CEPH mega-YAC clone, 955_e_11 that had been mapped to 1q21 (Marenholz et al., 1996; Lioumi et al., 1998) . Detailed mapping of this YAC clone was previously reported, indicating that it lies within a large genomic region at 1q21 called the epidermal dierentiation complex (EDC). EDC is one of the most gene-dense regions in the human genome, and contains more than 24 genes involved in epidermal dierentiation in a 1.2 Mb region. Considering the expression patterns, it is unlikely that hJTB is involved in epidermal differentiation. Indeed, it has been reported that some genes mapped to EDC are ubiquitously expressed. The ®nding that this region contains high copies of Alu elements (Figure 4) strengthens the hypothesis that the EDC is exceptionally gene-rich.
Discussion
It has been suggested that the extra copies of chromosome 1q are frequently associated with tumor progression. In these cases, unbalanced translocations involving 1q21-23 have been frequently documented. However, to date, no gene has been identi®ed at the breakpoints of these unbalanced translocations. In this study, we have cloned and characterized a novel gene hJTB at the 1q21 fusion point in a case of JT, a special type of unbalanced translocation. It would be interesting to determine whether hJTB participates in other forms of translocations involving 1q21.
We found that JT resulted in a truncated hJTB, which potentially produces soluble hJTB products lacking the trans-membrane domain. There is an interesting precedent in which the soluble forms of receptor proteins are exploited by viruses for their propagation (Upton, 1991) . Some highly-virulent pox viruses encode secreted proteins homologous to TNF receptors. After infection, this protein is actively produced by viruses to bind with the host TNFs, thus preventing them from binding to the host TNF receptors. In this way, the viruses disturb the host immune network, and acquire high tolerance to host defenses. Similarly, if hJTB binds to a ligand that has anti-oncogenic eects, secretion of soluble hJTB may mask the cancer cells from the host's defense systems. Overexpression of the truncated form of hJTB in several hematopoietic cell lines did not produce any eect on cell growth in vitro (data not shown). However, as in the case of pox viruses, it is possible that the putative roles of mutant hJTB may only be observed in vivo. A study is in progress to test this possibility.
In contrast to the hypothesis that the truncated hJTB may contribute to the growth advantage of the cancer cells, it is still possible that the hJTB mutation does not have any adaptive signi®cance for cancer progressions, and that it is simply a consequence of LTF in the cancer cells. In this sense, it is intriguing that hJTB is located in the EDC region. EDC is a region of about 2.2-Mb at 1q21, and contains a large number of genes that are mostly expressed in epidermal cells (Marenholz et al., 1996) . These genes can be assorted into two groups depending on the protein structures, namely the S100 gene family (characterized by possessing calcium-binding EF-hand motifs) and the SPRR (small proline-rich region) family. It has been suggested that genes belonging to the same family evolved from a prototype gene by gene duplication mechanisms. It also has been proposed that the expression patterns of genes present in EDC is controlled by common cis-elements demarcating the region, analogous with the locus control region (LCR) of the b-globulin genes complex. In any case, the chromatin structures of the 2 Mb EDC region seem to be uniformly controlled to be either open or closed, and the genes present in EDC may be easily translocated (as re¯ected by repeated gene duplications). The chromosomal ends lacking telomeres after excessive proliferation during MDS might have preferentially attacked this open-structured and vulner- Figure 5 JTB in the EDC region. The positions of the YAC 955_e_11 clone in the EDC is indicated along with several STS markers and genes known to be present in EDC. S100A6, S100A8, S100A9 and LOR (gene name) are members of the S100 gene family, whereas SPRR2A, SPRR1B, SPRR3 and IVL are members of the SPRR family. JTB is¯anked by two STS markers, D1S3384 and D1S2463 (below), which are known to be present in the YAC 955_e_ 11 clone. However, these two markers have not been precisely mapped and the relative position of JTB in EDC is to be determined able EDC complex to produce JTs. Further characterization of biological roles of hJTB will be necessary for elucidating the signi®cance of JT.
Materials and methods
Northern hybridization of hJTB
Three multiple tissue Northern blots (Clontech) containing 2 mg/lane of poly(A) + RNA from eight human tissues and cell lines were purchased from Clontech. The ®lters were preincubated in RNA hybridization solution (56SSC, 56Denhardt's solution, 100 mg/ml denatured herring sperm DNA, 0.5% SDS and 50% formamide) for 2 h at 428C and hybridized for 20 h at 428C with a 32 Pradiolabeled probe obtained using a Nick Translation kit (Boehringer-Mannheim) and a 250 bp BamHI/PstI fragment that is located 2.0 kb from the JT breakpoint. The blot was washed twice at room temperature with 26SSC, 0.1% SDS; and 0.16SSC, 0.5% SDS (20 min in each solution). Autoradiography was performed for 2 days at 7808C using a Hyper®lm (Amersham).
Isolation of hJTB and rJTB
cDNA libraries from PA-1, a human ovarian teratocarcinoma cell line (a gift from J Nakayama) and SV-3Y1-C66, SV40-transformed subline of 3Y1 rat ®broblasts (a gift from J Nakayama) were screened. Duplicate sets of ®lters were hybridized under the same conditions as described above. Two independent clones were isolated from the cDNA library and sequenced. All exons of hJTB were mapped by comparison of the cDNA with the genomic sequences.
Expression of hJTB
The full coding region of hJTB cDNA, corresponding to the 146 amino residues of the protein, was tagged at the 3'-end with the sequence encoding the FLAG. The predicted chimera protein has an expected molecular weight of about 17.5 kDa. The construct was inserted into the eukaryotic plasmid vector pcDNA3 (Invitrogen). The recombinant plasmid was transfected transiently in 293T cells by calcium phosphate precipitation. The total cellular proteins were radiolabeled with 35 S-methionine for 1 h. The speci®c translation products were immunoprecipitated using the anti-FLAG speci®c polyclonal antibody (Santa Cruz Biotechnology) and Protein A CL-4B (Pharmacia), and then electrophoresed through a 9.8% SDS-polyacrylamide gel. After ®xation with a 10% acetic acid, 25% isopropanol solution, the gel was washed for 20 min in Enlightening (Dupon), dried and autoradiographed overnight on Hyper®lm (Amersham).
The extracellular region of hJTB cDNA, corresponding to the 109 amino residues of the protein, was tagged at the 3' end with the sequence encoding the sequence encoding the HA and six histidine. The predicted chimera protein has an expected molecular weight of about 13.9 kDa. The construct was inserted into the eukaryotic plasmid vector pSMT201. The recombinant plasmid was transfected transiently in CHO cells as described above. The total cellular proteins or conditioned medium were immunoblotted with anti-HA monoclonal antibody, 12CA5 (Boehringer Mannheim).
Computational analysis
The other homologs of hJTB were identi®ed using dbEST with nucleotide sequences obtained from hJTB cDNA through the BLASTN option. Analysis of the JTBs amino acid sequences for the identi®cation of signal peptide was performed using PSORT (http://psort.nibb.ac.jp/) software package.
GenBank accession numbers
The GenBank accession numbers for the human, rat, mouse, Brugia malayi JTB cDNA sequences, the wild type JTB genomic sequence and the JT allele of the JTB genomic sequence are AB016488, AB016489, AB016490, AB016491, AB016492 and AB016493, respectively.
